18 companies Optum Ventures invested in this year

Optum Ventures, Optum's venture capital arm, has grown significantly over the past four years, from investing $7.5 million in 2016 to $654 million so far in 2020.

Here are 18 companies Optum Ventures invested in this year.

1. Springtide Child Development, a care platform for children with developmental delays, as part of $18.13 million Series A funding

2. Buoy Health, a symptom checker and care triage platform, as part of $37 million Series C funding

3. Diameter Health, a data optimization company, as part of $18 million Series B funding

4. Truepill, an API-connected healthcare infrastructure, as part of $75.5 million Series C funding

5. mPulse Mobile, which has health plan member engagement and communication software, as part of $16 million Series C funding

6. Lumeon, a digital health company with care automation software, as part of $30 million Series D funding

7. ClusterTruck, a delivery only restaurant, as part of $2 million unattributed venture capital funding

8. Dispatch Health, a platform for on-demand acute care from home, as part of $135.8 million Series C funding

9. Somatus, a company focused on preventing chronic kidney disease progression, as part of $64 million Series C funding

10. Kaia Health, a digital therapeutics company, as part of $26 million Series B funding

11. DocASAP, a patient engagement platform, as part of unattributed venture capital funding

12. Mindstrong, a neuropsychiatric disorders diagnosis and treatment platform, as part of $100 million Series C funding

13. Holmusk, a data science and therapeutics company, as part of $21.5 million Series A funding

14. Let'sGetChecked, an at-home testing company for multiple conditions, as part of $71 million Series C funding

15. Heartbeat, a telemedicine and virtual care platform, as part of $8.2 million Series A funding

16. RubiconMD, a primary care virtual consult platform, as part of $18 million Series C funding

17. Scipher Medicine, a biopharma focused network-sciences company, as part of Series B-II funding

18. Oxford VR, a company with clinically validated virtual reality technology, as part of $12.5 million Series A funding

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy
.
 

Articles We Think You'll Like